GADGVGKSA

This synthetic GADGVGKSA peptide corresponds to the immunogenic neoantigen encoded by the KRAS G12D mutation. It is utilized in cancer immunotherapy research for in vitro T-cell activation assays and in vivo studies evaluating neoantigen-specific vaccine efficacy.